Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

A pooled analysis of bone marrow micrometastasis in breast cancer.

Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A, Pantel K.

N Engl J Med. 2005 Aug 25;353(8):793-802.

2.

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G.

J Natl Cancer Inst. 1996 Nov 20;88(22):1652-8.

3.

Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.

Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbeck C, Rjosk D, Hepp F.

J Clin Oncol. 2001 Mar 1;19(5):1468-75.

PMID:
11230493
4.

Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.

Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P, Heinecke A, Pantel K, Izbicki JR.

J Natl Cancer Inst. 2005 Dec 21;97(24):1840-7.

5.

Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.

Jung YS, Lee KJ, Kim HJ, Yim HE, Park JS, Soh EY, Kim MW, Park HB.

Jpn J Clin Oncol. 2003 Apr;33(4):167-72.

6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
7.

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

Braun S, Pantel K, Müller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmüller G, Schlimok G.

N Engl J Med. 2000 Feb 24;342(8):525-33. Erratum in: N Engl J Med 2000 Jul 27;343(4):308.

8.

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.

Willner J, Kiricuta IC, Kölbl O.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63.

PMID:
9128962
10.

Bone marrow micrometastasis in breast cancer.

Ozbas S, Dafydd H, Purushotham AD.

Br J Surg. 2003 Mar;90(3):290-301. Review.

PMID:
12594663
11.

A gene-expression signature as a predictor of survival in breast cancer.

van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R.

N Engl J Med. 2002 Dec 19;347(25):1999-2009.

12.

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.

Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B.

J Clin Oncol. 2003 Sep 15;21(18):3469-78.

PMID:
12972522
13.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

14.

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.

Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S.

J Natl Cancer Inst. 1996 Dec 4;88(23):1764-9.

15.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
16.

Sentinel node micrometastasis and distant failure in breast cancer patients.

Nagashima T, Sakakibara M, Nakano S, Tanabe N, Nakamura R, Nakatani Y, Nagai Y, Koda K, Miyazaki M.

Breast Cancer. 2006;13(2):186-91.

17.

Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.

Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ.

J Natl Cancer Inst. 1996 Nov 20;88(22):1659-64.

18.

Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.

Gilje B, Nordgård O, Tjensvoll K, Janssen EA, Søiland H, Smaaland R, Baak JP.

Breast Cancer Res Treat. 2011 Jul;128(1):137-46. doi: 10.1007/s10549-011-1487-1. Epub 2011 Apr 8.

PMID:
21476002
19.

Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.

van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA.

Eur J Surg Oncol. 2002 Aug;28(5):481-9.

PMID:
12217299
20.

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H, Tominaga T.

J Natl Cancer Inst. 1997 Jan 15;89(2):139-47.

Items per page

Supplemental Content

Write to the Help Desk